InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,279.79
(
0.30%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

caravon

Send PM Follow Ignore
Followers 13
Posts 1058
Boards Moderated 0
Alias Born 02/21/2007

caravon

Re: mcbio post# 180983

Wednesday, 08/06/2014 9:27:41 AM

Wednesday, August 06, 2014 9:27:41 AM

Post# of 252302

The data in the P3 MARQUEE NSCLC trial has still not matured for the EGFR mutant sub-group.



What are they waiting for?

With recent restructuring, cash runway has been extended another year (into 2017 now).


Stop paying Pucci $750,000/y plus bonuses. Cut ARQL sr. management compensation by at least 10-20%


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up